| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bicalutamide | FIMM | pan-cancer | AAC | -0.45 | 0.007 |
| mRNA | foretinib | CTRPv2 | pan-cancer | AAC | 0.091 | 0.008 |
| mRNA | navitoclax:pluripotin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.092 | 0.008 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | -0.13 | 0.008 |
| mRNA | AZD8055 | GDSC1000 | pan-cancer | AAC | 0.09 | 0.008 |
| mRNA | 681640 | GDSC1000 | pan-cancer | AAC | 0.098 | 0.009 |
| mRNA | austocystin d | CTRPv2 | pan-cancer | AAC | -0.091 | 0.01 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | -0.12 | 0.01 |
| mRNA | NG-25 | GDSC1000 | pan-cancer | AAC | 0.073 | 0.01 |
| mRNA | Ki8751 | CTRPv2 | pan-cancer | AAC | 0.083 | 0.02 |